Integrum Q3: In line and no estimate changes
Research Update
2024-03-01
08:30
Redeye sees a quarter developing per our expectations, and we make no estimate revisions. We continue to see upside potential to our base case, but we point to the extreme share price development in the past six months and argue that shorter-term sell-offs pose a risk to the stock.
OB
Oscar Bergman
Analyst Q&A
Closed
Oscar Bergman answered 6 questions.
Disclosures and disclaimers